These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33032466)

  • 1. Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials.
    Freynhagen R; Elling C; Radic T; Sohns M; Liedgens H; James D; McCool R; Edwards M
    Curr Med Res Opin; 2021 Jan; 37(1):89-100. PubMed ID: 33032466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of Opioid Analgesia for Chronic Pain: A Network Meta-Analysis.
    Meng Z; Yu J; Acuff M; Luo C; Wang S; Yu L; Huang R
    Sci Rep; 2017 May; 7(1):1995. PubMed ID: 28515426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain.
    Sánchez Del Águila MJ; Schenk M; Kern KU; Drost T; Steigerwald I
    Clin Ther; 2015 Jan; 37(1):94-113. PubMed ID: 25108647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of tapentadol in chronic severe pain.
    Riemsma R; Forbes C; Harker J; Worthy G; Misso K; Schäfer M; Kleijnen J; Stürzebecher S
    Curr Med Res Opin; 2011 Oct; 27(10):1907-30. PubMed ID: 21905968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies].
    Merker M; Dinges G; Koch T; Kranke P; Morin AM
    Schmerz; 2012 Feb; 26(1):16-26. PubMed ID: 22366930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Tapentadol Immediate Release for Acute Pain: A Systematic Review and Meta-Analysis.
    Wang X; Narayan SW; Penm J; Patanwala AE
    Clin J Pain; 2020 May; 36(5):399-409. PubMed ID: 31990693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opioids in chronic noncancer pain-are opioids different? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week's duration].
    Lauche R; Klose P; Radbruch L; Welsch P; Häuser W
    Schmerz; 2015 Feb; 29(1):73-84. PubMed ID: 25376545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Opioid Analgesics for the Management of Chronic Low Back Pain: An Evidence from Bayesian Network Meta-Analysis.
    Boya C; Bansal D; Kanakagiri S; Ghai B
    Pain Physician; 2021 Jan; 24(1):73-82. PubMed ID: 33400430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain.
    Kress HG; Koch ED; Kosturski H; Steup A; Karcher K; Lange B; Dogan C; Etropolski MS; Eerdekens M
    Pain Physician; 2014; 17(4):329-43. PubMed ID: 25054392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
    Sommer C; Klose P; Welsch P; Petzke F; Häuser W
    Eur J Pain; 2020 Jan; 24(1):3-18. PubMed ID: 31705717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
    Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of tapentadol in severe chronic pain in Spain: a cost analysis of data from RCTs.
    Obradovic M; Ikenberg R; Hertel N; Antoñanzas F; Gálvez R; Liedgens H
    Clin Ther; 2012 Apr; 34(4):926-43. PubMed ID: 22417717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapentadol extended release for chronic pain patients.
    Taylor R; Pergolizzi JV; Raffa RB
    Adv Ther; 2013 Jan; 30(1):14-27. PubMed ID: 23328938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate use of tapentadol: focus on the optimal tapering strategy.
    Vellucci R; Fornasari D
    Curr Med Res Opin; 2023 Jan; 39(1):123-129. PubMed ID: 36427080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials.
    Lange B; Sohns M; Tempero J; Elling C
    Curr Med Res Opin; 2018 Dec; 34(12):2113-2123. PubMed ID: 30200781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action.
    Caputi FF; Nicora M; Simeone R; Candeletti S; Romualdi P
    Minerva Med; 2019 Feb; 110(1):62-78. PubMed ID: 30667206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
    Etropolski M; Kuperwasser B; Flügel M; Häufel T; Lange B; Rauschkolb C; Laschewski F
    Adv Ther; 2014 Jun; 31(6):604-20. PubMed ID: 24985410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain.
    Furlan A; Chaparro LE; Irvin E; Mailis-Gagnon A
    Pain Res Manag; 2011; 16(5):337-51. PubMed ID: 22059206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.